Title : HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide.

Pub. Date : 2015 Oct 13

PMID : 26429859






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, we show that a novel pan-HDACi AR-42 downregulates CD44, a glycoprotein that has been associated with lenalidomide and dexamethasone resistance in myeloma both in vitro and in vivo. Lenalidomide CD44 molecule (Indian blood group) Homo sapiens
2 Thus, our findings shed light on potential novel combinatorial therapeutic approaches modulating CD44 expression, which may help overcome lenalidomide resistance in myeloma patients. Lenalidomide CD44 molecule (Indian blood group) Homo sapiens